1. European Pressure Ulcer Advisory Panel, National Pressure Injury Advisory Panel and Pan Pacific Pressure Injury Alliance. Prevention and Treatment of Pressure Ulcers/Injuries: Clinical Practice Guideline. Emily Haesler (Ed.). EPUAP/NPIAP/PPPIA: 2019.
2. Smith+Nephew 2020. Internal report. PSS415.
3. Monograph Title 21 CFR Part 347 - Skin Protectant Drug Products for Over the Counter Human Use Final Monograph 06/2003.
4. Fiers, S.A. OWM, vol 43, no 3, April 1996, 32-42.
5. Scheps M.H. Home Health Care Consultant, vol 3l NO 1, Jan-Feb 1996, 37-39.
6. Smith+Nephew 2019. Internal report. RD/19/026/v2.
7. Hilltop Research 2007. Internal report. 07-128386-111.
8. Nursing Care Moisturizing Cream Formulation (F-50). 2009.
9. Evaluation of Cumulative Irritation Potential in Humans (21-day), Report # 94-2404-72A, Hill Top Research.
10. Monograph Title 21 CFR Part 347 - Skin Protectant Drug Products for Over the Counter Human Use final Monograph 06/2003.
11. Brett, D. The justification of Secure Anti-Fungal Extra Thick Cream formulated to not wash away even in severe cases of diarrhea and soothing and gentle to the skin. 2017.
12. Title 21 CFR, Part 333, SubpartC - Topical Antifungal Drug Products.
13. Smith+Nephew 2020. The justification of pH buffered claim for the total body foam cleanser (TBFCI). Internal report.
14. Microbiotest report: Chlorhexidine Gluconate compatibility Evaluation of Skin Treatment Products. 2020.